KR20170026486A - 저혈압 치료 방법 - Google Patents

저혈압 치료 방법 Download PDF

Info

Publication number
KR20170026486A
KR20170026486A KR1020177001649A KR20177001649A KR20170026486A KR 20170026486 A KR20170026486 A KR 20170026486A KR 1020177001649 A KR1020177001649 A KR 1020177001649A KR 20177001649 A KR20177001649 A KR 20177001649A KR 20170026486 A KR20170026486 A KR 20170026486A
Authority
KR
South Korea
Prior art keywords
angiotensin
patient
composition
rate
administered
Prior art date
Application number
KR1020177001649A
Other languages
English (en)
Korean (ko)
Inventor
조지 티드마시
Original Assignee
라 졸라 파마슈티칼 컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라 졸라 파마슈티칼 컴파니 filed Critical 라 졸라 파마슈티칼 컴파니
Publication of KR20170026486A publication Critical patent/KR20170026486A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020177001649A 2014-07-08 2015-07-08 저혈압 치료 방법 KR20170026486A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08
US62/022,054 2014-07-08
PCT/US2015/039499 WO2016007589A1 (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Publications (1)

Publication Number Publication Date
KR20170026486A true KR20170026486A (ko) 2017-03-08

Family

ID=55064810

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177001649A KR20170026486A (ko) 2014-07-08 2015-07-08 저혈압 치료 방법

Country Status (14)

Country Link
US (3) US20160074465A1 (pt-PT)
EP (2) EP3381465A1 (pt-PT)
JP (2) JP2017519799A (pt-PT)
KR (1) KR20170026486A (pt-PT)
CN (1) CN106794224A (pt-PT)
AU (2) AU2015287955A1 (pt-PT)
BR (1) BR112017000303A2 (pt-PT)
CA (1) CA2954016A1 (pt-PT)
EA (2) EA202091873A3 (pt-PT)
IL (1) IL249936A0 (pt-PT)
MX (1) MX2017000306A (pt-PT)
SG (2) SG11201610897VA (pt-PT)
TW (3) TWI754225B (pt-PT)
WO (1) WO2016007589A1 (pt-PT)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200046957A (ko) 2018-10-26 2020-05-07 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
PL2986308T3 (pl) * 2013-12-18 2020-05-18 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensyna ii w połączeniu do leczenia niedociśnienia
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US10406201B2 (en) 2016-01-07 2019-09-10 La Jolla Pharma, Llc Methods for administering angiotensin II
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
US20190183962A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
US10653646B2 (en) 2018-03-23 2020-05-19 Nevakar Inc. Epinephrine compositions and containers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
CN101316626A (zh) * 2005-09-29 2008-12-03 菲布罗根公司 用于降低血压的方法
US20100172862A1 (en) * 2008-11-28 2010-07-08 Abbott Laboratories Stable antibody compositions and methods of stabilizing same
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
PL2986308T3 (pl) * 2013-12-18 2020-05-18 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensyna ii w połączeniu do leczenia niedociśnienia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200046957A (ko) 2018-10-26 2020-05-07 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Also Published As

Publication number Publication date
EA202091873A3 (ru) 2021-01-29
WO2016007589A1 (en) 2016-01-14
EP3007722A4 (en) 2016-05-25
EA036514B1 (ru) 2020-11-18
MX2017000306A (es) 2017-07-10
AU2015287955A1 (en) 2017-02-02
US20180311306A1 (en) 2018-11-01
TWI688385B (zh) 2020-03-21
TW201625231A (zh) 2016-07-16
TW202214219A (zh) 2022-04-16
TWI754225B (zh) 2022-02-01
CA2954016A1 (en) 2016-01-14
BR112017000303A2 (pt) 2017-11-07
JP2017519799A (ja) 2017-07-20
IL249936A0 (en) 2017-03-30
SG11201610897VA (en) 2017-01-27
TW202038927A (zh) 2020-11-01
US20160074465A1 (en) 2016-03-17
EP3381465A1 (en) 2018-10-03
EA202091873A2 (ru) 2020-11-30
US20200237853A1 (en) 2020-07-30
AU2021201669A1 (en) 2021-04-08
SG10201804034QA (en) 2018-07-30
EA201692534A1 (ru) 2017-06-30
JP2020143139A (ja) 2020-09-10
CN106794224A (zh) 2017-05-31
EP3007722A1 (en) 2016-04-20

Similar Documents

Publication Publication Date Title
KR20170026486A (ko) 저혈압 치료 방법
US11219662B2 (en) Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
US11583568B2 (en) Methods for administering angiotensin II
KR20180108630A (ko) 혈관수축제의 투여 방법
AU2014256944B2 (en) Compositions and methods for treating renal failure
WO2020252333A1 (en) Methods for administering angiotensin ii by monitoring renin levels
WO2020018785A1 (en) Methods of treating angioedema

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E601 Decision to refuse application